Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment
Author:
Funder
National Institutes of Health
Publisher
MDPI AG
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology
Link
http://www.mdpi.com/2076-393X/6/2/30/pdf
Reference53 articles.
1. Global Tuberculosis Report 2017,2017
2. How does the level of BCG vaccine protection against tuberculosis fall over time?
3. Treatment of tuberculosis: Guidelines,2010
4. Safety and immunogenicity of the M72/AS01 E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study
5. Tuberculosis vaccines: Opportunities and challenges
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. TB/FLU-06E Influenza Vector-Based Vaccine in the Complex Therapy of Drug-Susceptible and Drug-Resistant Experimental Tuberculosis;Pharmaceutics;2024-06-25
2. Mucosal and systemic immune responses after a single intranasal dose of nanoparticle and spore-based subunit vaccines in mice with pre-existing lung mycobacterial immunity;Frontiers in Immunology;2023-12-07
3. Importance of adjuvant selection in tuberculosis vaccine development: Exploring basic mechanisms and clinical implications;Vaccine: X;2023-12
4. An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis;Vaccines;2023-01-05
5. Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen;Tuberculosis;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3